Cargando…

The complexity of interpreting genomic data in patients with acute myeloid leukemia

Acute myeloid leukemia (AML) is a heterogeneous neoplasm characterized by the accumulation of complex genetic alterations responsible for the initiation and progression of the disease. Translating genomic information into clinical practice remained challenging with conflicting results regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nazha, A, Zarzour, A, Al-Issa, K, Radivoyevitch, T, Carraway, H E, Hirsch, C M, Przychodzen, B, Patel, B J, Clemente, M, Sanikommu, S R, Kalaycio, M, Maciejewski, J P, Sekeres, M A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223150/ https://www.ncbi.nlm.nih.gov/pubmed/27983727 http://dx.doi.org/10.1038/bcj.2016.115

Ejemplares similares

Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
por: Saygin, Caner, et al.
Publicado: (2018)

Molecular features of early onset adult myelodysplastic syndrome
por: Hirsch, Cassandra M., et al.
Publicado: (2017)

Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes
por: Nazha, A, et al.
Publicado: (2017)

Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide
por: Negoro, Eiju, et al.
Publicado: (2016)

Distinctive and common features of moderate aplastic anaemia
por: Patel, Bhumika J., et al.
Publicado: (2020)

Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms
por: Visconte, Valeria, et al.
Publicado: (2016)

Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine
por: Visconte, Valeria, et al.
Publicado: (2015)

Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML
por: Przychodzen, Bartlomiej, et al.
Publicado: (2017)

Molecular landscape in acute myeloid leukemia: where do we stand in 2016
por: Al-Issa, Karam, et al.
Publicado: (2016)

Myb expression is critical for myeloid leukemia development induced by Setbp1 activation
por: Nguyen, Nhu, et al.
Publicado: (2016)

Extended experience with a non‐cytotoxic DNMT1‐targeting regimen of decitabine to treat myeloid malignancies
por: Awada, Hassan, et al.
Publicado: (2019)

Rational management approach to pure red cell aplasia
por: Balasubramanian, Suresh Kumar, et al.
Publicado: (2018)

Emerging therapies for acute myeloid leukemia
por: Saygin, Caner, et al.
Publicado: (2017)

Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia
por: Guan, Yihong, et al.
Publicado: (2020)

Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development
por: Vishwakarma, Bandana A., et al.
Publicado: (2015)

Parameter perturbations in a post-treatment chronic myeloid leukemia model capture the essence of pre-diagnosis A-bomb survivor mysteries
por: Radivoyevitch, Tomas
Publicado: (2020)

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin
por: Duong, Hien K, et al.
Publicado: (2009)

Karyotype complexity and prognosis in acute myeloid leukemia
por: Stölzel, F, et al.
Publicado: (2016)

Complex Landscape of Alternative Splicing in Myeloid Neoplasms
por: Hershberger, Courtney E., et al.
Publicado: (2020)

Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies
por: Singh, H, et al.
Publicado: (2013)

PRPF8 Defects Cause Missplicing in Myeloid Malignancies
por: Kurtovic-Kozaric, Amina, et al.
Publicado: (2014)

Recurrent genetic defects on chromosome 5q in myeloid neoplasms
por: Hosono, Naoko, et al.
Publicado: (2016)

Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes
por: Nagata, Yasunobu, et al.
Publicado: (2019)

CLINICAL AND BIOLOGICAL IMPLICATIONS OF ANCESTRAL AND NON-ANCESTRAL IDH1 AND IDH2 MUTATIONS IN MYELOID NEOPLASMS
por: Molenaar, Remco J., et al.
Publicado: (2015)

Guide to Interpreting Disease Responses in Chronic Myeloid Leukemia
por: Galinsky, Ilene, et al.
Publicado: (2012)

Molecular patterns identify distinct subclasses of myeloid neoplasia
por: Kewan, Tariq, et al.
Publicado: (2023)

Prediction of CR following a second course of ‘7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first course
por: Othus, M, et al.
Publicado: (2016)

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
por: Hill, Brian T, et al.
Publicado: (2015)

Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
por: Hurtado, A M, et al.
Publicado: (2015)

Interpreting Molecular Monitoring Results and International Standardization in Chronic Myeloid Leukemia
por: Bauer, Stephanie, et al.
Publicado: (2012)

Myeloid leukemia after hematotoxins.
por: Larson, R A, et al.
Publicado: (1996)

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients
por: Advani, Anjali S, et al.
Publicado: (2010)

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
por: Zarka, Jabra, et al.
Publicado: (2020)

Demethylator phenotypes in acute myeloid leukemia
por: Kelly, Andrew D., et al.
Publicado: (2018)

New drugs for pharmacological extension of replicative life span in normal and progeroid cells
por: Vatolin, Sergei, et al.
Publicado: (2019)

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
por: Steensma, David P., et al.
Publicado: (2016)

Chronic Myeloid Leukemia Preceded by Tuberculosis
por: Al-Qudah, Bara M., et al.
Publicado: (2020)

Targeting the GFI1/1B—CoREST Complex in Acute Myeloid Leukemia
por: van Bergen, Maaike G. J. M., et al.
Publicado: (2019)

From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2020)

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
por: Bidikian, Aram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pfgo5uggdh5tc9diaok1fv3ss3